Learn why St. Luke’s DNA Answers has already completed more than 30,000 genetic screenings to find predisposition for genetic ...

The conversation centred on the company’s latest developments and strategic direction in cancer therapies, with a particular ...

Triangle-based Continuous Precision Medicine developed a mobile app to track pain management and prescription medication ...

As National Cancer Survivors Month begins, survivors and medical professionals are highlighting the impact of personalized ...

Radiopharmaceuticals are transforming modern medicine, while simultaneously intensifying the pressures on pharmaceutical ...

Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...

Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...

Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo's CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 ...

Researchers at Western Sydney University have developed an AI-powered tool that uses dynamic risk scores based on blood ...

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - ...